BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24498965)

  • 1. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients.
    Hashimoto N; Matsuzaki A; Okada Y; Imai N; Iwano S; Wakai K; Imaizumi K; Yokoi K; Hasegawa Y
    BMC Pulm Med; 2014 Feb; 14():14. PubMed ID: 24498965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
    Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
    AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
    Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer resection and postoperative outcomes in COPD: A single-center experience.
    Roy E; Rheault J; Pigeon MA; Ugalde PA; Racine C; Simard S; Chouinard G; Lippens A; Lacasse Y; Maltais F
    Chron Respir Dis; 2020; 17():1479973120925430. PubMed ID: 32468842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer.
    Corriveau S; Pond GR; Tang GH; Goffin JR
    BMC Cancer; 2021 Jan; 21(1):14. PubMed ID: 33402114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer.
    Loganathan RS; Stover DE; Shi W; Venkatraman E
    Chest; 2006 May; 129(5):1305-12. PubMed ID: 16685023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure.
    Arnaudis B; Lairez O; Escamilla R; Fouilloux A; Fournier P; Monteil B; Bouisset F; Arnal JF; Elbaz M; Carrié D; Roncalli J; Pathak A; Galinier M
    Clin Res Cardiol; 2012 Sep; 101(9):717-26. PubMed ID: 22484345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
    Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
    Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.
    Hashimoto N; Ando A; Iwano S; Sakamoto K; Okachi S; Matsuzaki A; Okada Y; Wakai K; Yokoi K; Hasegawa Y
    BMC Pulm Med; 2018 Jan; 18(1):2. PubMed ID: 29304775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
    Young RP; Hopkins RJ; Christmas T; Black PN; Metcalf P; Gamble GD
    Eur Respir J; 2009 Aug; 34(2):380-6. PubMed ID: 19196816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.
    Qin J; Li G; Zhou J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1515-20. PubMed ID: 27445471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease.
    Bajc M; Chen Y; Wang J; Li XY; Shen WM; Wang CZ; Huang H; Lindqvist A; He XY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1579-1587. PubMed ID: 28603413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.